Founded in 2013, AbbVie is a biopharmaceutical company that discovers, develops, and sells pharmaceutical products. The company came into being following a split of Abbott Laboratories into two. The new Abbott went on to specialize in medical devices as well as diagnostic equipment while AbbVie transitioned into a biopharmaceutical company.

Headquartered in North Chicago, Illinois, the company operates as a research-based pharmaceutical company with a 30,000-employee base made up of scientist’s researchers, manufacturing specialists, and regulatory experts.

The company’s products treat conditions such as chronic autoimmune diseases, oncology, rheumatology, and dermatology. It’s lead products include Humira, a novel treatment for autoimmune conditions and intestinal Behcet’s diseases, and accounts for nearly half of the company’s drug division revenue. Imbruvica is the company’s novel treatment for chronic lymphocytic leukemia.

Divestiture of AbbVie from Abbott Laboratories resulted in its listing on the New York Stock Exchange in 2013.

Investing is speculative. When investing your capital is at risk. This site is not intended for use in jurisdictions in which the trading or investments described are prohibited and should only be used by such persons and in such ways as are legally permitted. Your investment may not qualify for investor protection in your country or state of residence, so please conduct your own due diligence. This website is free for you to use but we may receive commission from the companies we feature on this site. Click here for more information.